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Abstract
The Paleolithic diet excludes two major sources of fibre, grains and legumes. However, it is not known whether this results in changes to
resistant starch (RS) consumption. Serum trimethylamine-N-oxide (TMAO) is produced mainly from colonic fermentation and hepatic
conversion of animal protein and is implicated in CVD, but changes in RS intake may alter concentrations. We aimed to determine whether
intake of RS and serum concentrations of TMAO varied in response to either the Paleolithic or the Australian Guide to Healthy Eating (AGHE)
diets and whether this was related to changes in food group consumption. A total of thirty-nine women (mean age 47 (SD 13) years, BMI 27
(SD 4) kg/m2) were randomised to AGHE (n 17) or Paleolithic diets (n 22) for 4 weeks. Serum TMAO concentrations were measured using
liquid chromatography–MS; food groups, fibre and RS intake were estimated from weighed food records. The change in TMAO concentrations
between groups (Paleolithic 3·39 µM v. AGHE 1·19 µM, P= 0·654) did not reach significance despite greater red meat and egg consumption in
the Paleolithic group (0·65 serves/d; 95% CI 0·2, 1·1; P< 0·01, and 0·22 serves/d; 95% CI 0·1, 0·4, P< 0·05, respectively). RS intake was
significantly lower on the Paleolithic diet (P< 0·01) and was not associated with TMAO concentrations. However, the limited data for RS and
the small sample size may have influenced these findings. While there were no significant changes in TMAO concentrations, increased meat
consumption and reduced RS intake warrant further research to examine the markers of gastrointestinal health of Paleolithic diet followers and
to update Australian food databases to include additional fibre components.
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Previous research on the Paleolithic diet has examined its
impact on cardiovascular, anthropometric and metabolic out-
comes(1–9). The elimination of cereals, legumes and dairy pro-
ducts from the Paleolithic diet means food patterns are likely to
change significantly, yet there is little research on the changes in
intake from the core food groups(4,5,10). Although dietary fibre
intake on a Paleolithic diet is often not significantly different,
when compared with a control or standard diet(3–8,10), it has yet
to be established whether the dietary fibre profile is altered.
Grains and pulses are important sources of a particular type of
dietary fibre, resistant starch (RS). RS offers a range of health
benefits mediated through the products of its fermentation by
colonic bacteria(11).
Determination of RS content is problematic because levels
differ depending on food preparation and cooking methods,
storage conditions, level of ripeness and measurement
technique(12). Current estimates of RS in an Australian diet are
3·4–9·4 g/d(13), but it has been suggested that increasing intake
to approximately 20 g/d may be required to obtain health
benefits from the prebiotic capacity(14). Therefore, RS intake on
a Paleolithic diet requires quantification to understand potential
implications for the long-term gut and overall health outcomes.
Trimethylamine (TMA) is produced in vivo by the microbiota
of the bowel, from consumption of choline, phosphatidylcho-
line and L-carnitine(15,16). Choline and phosphatidylcholine are
found predominately in milk, liver, meat, eggs and peanuts(17),
and L-carnitine are predominately found in red meat(15). TMA is
converted in the liver to trimethylamine-N-oxide (TMAO)(18).
Wang et al.(16) showed that TMAO was a dose-dependent
predictor of CVD risk in a cohort of 1876 subjects and positively
correlated with atherosclerotic plaque size (Pearson correlation
R 0·42, P< 0·001) in a rodent study. An evaluation of the
prognostic value of TMAO concentrations showed that patients
with heart failure had significantly higher plasma TMAO
Abbreviations: AGHE, Australian Guide to Healthy Eating; CHO, carbohydrate; RS, resistant starch; TMA, trimethylamine; TMAO, trimethylamine-N-oxide.
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concentrations, associated with an increase in mortality (3·4
times) risk(19). It is still not understood whether TMAO is a
causative or correlative factor in atherosclerotic plaque devel-
opment, and more research is required to understand the link
with CVD. TMAO is filtered and excreted by kidneys into the
urine and elevations in serum TMAO may merely be a marker
of reduced kidney function, often co-existing with coronary
atherosclerosis(20). Similarly the increased risk of colorectal
cancer associated with plasma TMAO in women(21) may merely
be a demonstrating that TMAO serves as a marker for red and
processed meat consumption, which are already established
risk factors for this disease(22). Egg and red meat consumption
elevate plasma TMAO concentrations in the 24 h following
consumption(20,23). For seafood, which is a source of pre-
formed TMAO, the postprandial rise in circulating levels can be
detected within 15min of consumption(24), indicating that
TMAO is rapidly absorbed from the upper gut, without entering
the colon(24). Individual variation in gut microbiota composition
may also influence the production of TMAO in response to
dietary sources of choline and L-carnitine(24). A recent paper
reported that diets high in RS (19–27 g/d), but low in carbohy-
drate (CHO), were also associated with increased plasma
TMAO concentrations(25). This suggests that colonic CHO fer-
mentation may play a significant role in mediating microbial
populations, which produce TMA. CHO intake are restricted on
the Paleolithic diet, with cereal fibres excluded; therefore, it is
important to understand how this dietary pattern might influ-
ence circulating TMAO concentrations. We aimed to determine
whether fasting TMAO concentrations varied in healthy subjects
randomised to either the Paleolithic or the Australian Guide to
Healthy Eating (AGHE) diet, for a 4-week intervention and the
relationship with dietary RS, total fibre and food group intake.
Methods
The current data were part of a larger study described else-
where(3). In brief, a 4-week dietary intervention was conducted
in thirty-nine healthy females (mean age 47 (SD 13) years, BMI
27 (SD 4) kg/m2) using ad libitum Paleolithic (n 22) and AGHE
diets (n 17), with 3-d weighed food records collected pre- and
post-intervention(23). A priori sample size calculations were
based on an expected 15% reduction in the primary outcome
variable, total cholesterol, with 5% α-error and 80% power
between groups. Participants were locally recruited from areas
surrounding the university campus. The study was approved by
the Edith Cowan Human Research Ethics Committee (project
13402) and registered on the Australian and New Zealand
Register of Clinical Trials (ACTRN12615000246583).
Food group intake
To assess food group intake, the pre- and post-intervention 3-d
weighed food records collected previously(23) were re-analysed
using Australian software, FoodWorks Professional, version
8.0(26), with food group analysis enabled to provide intake of
the major food groups: grains, fruits, vegetables, protein foods
and dairy foods and intake of fats, oils and added sugars. There
were 1211 individual food items utilised for the 78, 3-d food
records analysed. A local copy of the database was made, and
within FoodWorks, each food item was updated to the
equivalent food item in the AUSFoods 2015(26) and AUSNUT
2013(27) databases. To assess fibre fraction intake, an additional
local copy of the database was made, with the NZFoodFiles
2014 data set enabled(28). Each food item was updated with
soluble and insoluble fibre content. Where data were missing
from FoodFiles 2014(29), or there was no appropriate match
with the consumed food, soluble and insoluble fibre data were
sourced from published literature(30–32). Minimum and max-
imum estimations were utilised for estimation of RS content
based on data published by Roberts et al.(13). All food items in
the database were updated with an RS value. Similar foods were
grouped, and RS content was assumed to be consistent across
the category. For example, estimations of RS content are
available for wholemeal, white, rye and flatbreads(13). There-
fore, breads were grouped into one of these categories, and RS
content was assumed to be consistent across the category.
Foods for which no data were available were assigned a value
of 0. Fibre and RS content of mixed dishes and recipes were
determined based on fibre/RS proportions of individual ingre-
dients within the recipe.
Trimethylamine-N-oxide analysis
TMAO analysis was conducted on fasting serum samples stored
at –20°C and collected as part of the study as described
previously(3). Serum was thawed, and 150 μl was transferred to
a 2-ml Eppendorf tube. Liquid chromatography (LC)–MS grade
acetonitrile (450 μl), containing 0·1 μg/ml of deuterated TMAO
(TMAO-d9) as the internal standard, was added to the serum.
The tube was vortexed for 30 s and centrifuged at 4000 rpm and
4°C for 10min. An aliquot (100 μl) of the supernatant was
transferred to a 2-ml HPLC vial, diluted with 75:25 acetonitrile
containing 0.1% formic acid: 100mM ammonium formate
(400 μl) and mixed thoroughly. Calibration standards in the
range of 0·05–5 μg/ml TMAO were prepared in 0·1% formic
acid and check standards (5, 0·25 and 0·05 μg/ml TMAO) were
prepared in synthetic serum and then processed using the same
procedure as for the samples. The calibration standards, check
standards and samples were analysed by LC–MS/MS using a
Thermo Scientific Ultimate 3000 Liquid Chromatograph and
coupled to a Thermo Scientific Quantiva triple quadrupole mass
spectrometer. The LC separation was achieved using an Intrada
amino acid column (150mm× 3·0 µm inner diameter) packed
with 3 µm particles. Aliquots (2 μl) were injected into the col-
umn and separated using a mobile phase of acetonitrile with
0·1% formic acid (A) and 100mM ammonium formate (B). Initial
mobile phase conditions were 75% A and 25% B held for 3min,
then B was increased to 100% over 4 min and maintained for
3min, and B was reduced to 25% over 0·1min and maintained
for 2min. The flow rate was 0·6ml/min, and the column was
maintained at 35°C. Detection was performed in positive mode
(3500V), and the analytes were ionised by electrospray and
monitored in multiple reaction monitoring mode. The MS was
operated under the following conditions: gases (arbitrary units)
sheath 52, auxiliary 16 and sweep 2; ion transfer tube
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temperature was 356°C; vapouriser temperature 420°C; transi-
tions of m/z 76·2 to m/z 48·2, 58·1 and 59·2 with collision
energies (eV) of 30, 16 and 11, respectively, were used to
monitor TMAO; transitions of m/z 85·2 to m/z 46·2, 66·2 and
68·2 with collision energies (eV) of 41, 21 and 11, respectively,
were used to monitor TMAO-d9.
Statistical analyses
Statistical analyses were conducted using SPSS for Windows,
version 23(33). Pre- and post-intervention data were examined
for normality using the Shapiro–Wilk test. Independent t test
and Mann–Whitney U test for non-normally distributed data
were performed to examine the differences between the two
groups in each of the dietary intake variables. Paired t test and
Wilcoxon signed-rank test were conducted to determine the
changes within groups. ANCOVA was used to examine the
associations between TMAO concentrations and changes in
dietary variables, with particular attention to protein and meat
servings, egg, solid fat and grain servings, in addition to RS
intake. Statistical significance was set at P< 0·05.
Results
Food group serves
As expected on a Paleolithic diet, there were significant
reductions in the consumption of total grains (–4·6 serves/d)
and dairy products (–1·5 serves/d) (P< 0·01 for both) (Table 1).
Post-intervention, the Paleolithic group had a higher intake of
protein foods (3·9 v. 2·6 serves/d), due to greater red meat
consumption, and higher intake of fruits (3·1 v. 1·2 serves/d)
and vegetables (5·8 v. 4·0 serves/d) (P< 0·01 for all), compared
with AGHE group. Whole grains contributed approximately half
of the total grain intake (55·2%) in the AGHE group. Con-
sumption of oil, solid fat equivalents and the percentage of
energy consumed as added sugars were not significantly dif-
ferent between groups.
Fibre
There were no significant differences between groups in total
dietary fibre, soluble or insoluble fibre intake (Table 2). Post-
intervention, the Paleolithic compared with AGHE group had a
significantly lower intake of total starch (–61·4 g/d, P< 0·01)
and RS, at both minimum (–1·18 g/d, P< 0·01) and maximum
(–3·54 g/d, P< 0·05) estimated intakes.
Trimethylamine-N-oxide
There were no significant differences between groups post-
intervention (Paleolithic median 6·79 (SD 12·92) µM v. AGHE 6·85
(SD 10·89) µM, P= 0·532) or change in serum TMAO concentra-
tion (Paleolithic median change 3·39 µM v. AGHE 1·19 µM,
P= 0·654, effect size= 0·10). The inclusion of protein serves,
solid fat, red meat, egg and grain serves in addition to estimates
of RS as covariates in the ANCOVA model did not alter this
finding.
Discussion
This dietary intervention in a group of thirty-nine healthy
women examined the differences in intake of core food groups
and types of fibre between the Paleolithic and AGHE diets. We
have reported total dietary fibre intake consistent with other
studies of the Paleolithic diet(4–6,8,10), however, the changes in
RS intake reported here represent new findings and may have
long-term health implications. Over the short-term intervention,
our results indicate that fasting serum concentrations of TMAO
were not influenced by the relative increase in serves of eggs
and red meat consumed on a Paleolithic diet or the decrease in
RS intake.
With the exclusion of grains, cereals, dairy products and
legumes on the Paleolithic diet, it was anticipated that dif-
ferences would occur in the intake of the protein food
group, which included meats, poultry, and alternatives such
as seafood, nuts and seeds and legumes. The increase we
found in the protein food group was attributable to greater
red meat and egg consumption, precursor foods for the
formation of TMAO(16). Despite the increased serves of fruits
and vegetables consumed in the Paleolithic group and the
maintenance of total dietary fibre intake, RS was negatively
impacted by the elimination of whole grains, cereals and
legumes. In the AGHE dietary intervention group, we also
note no increase in consumption of legumes, which provide
a good source of RS(13), and may provide an area where
these data can guide future interventions using the AGHE.
While RS intake was low on the Paleolithic diet, RS can be
obtained on a Paleolithic diet from root vegetables and
bananas(13).
SCFA (primarily acetate, propionate and butyrate) are pro-
ducts of bacterial fermentation of CHO in the colon(34).
Butyrate, in particular, contributes to the maintenance of
colonic epithelia(35). Previous research has shown that low-
CHO diets decrease total faecal SCFA concentrations and total
daily faecal SCFA excretion when compared with energy-
restricted high-CHO diets(36). Consumption of RS is known to
increase the faecal output of SCFA, and epidemiological evi-
dence suggests it is protective against colorectal cancer(35). As
evidence emerges on the link between diet and bacterial
populations inhabiting the bowel(36–38), the reduction in RS
intake we have reported may also reduce colonic SCFA pro-
duction, which may, in turn, increase the risk of developing
non-infectious digestive disorders(36,39). Bergeron et al.(25)
recently reported that plasma TMAO concentrations were
increased, in a 2-week crossover study using high CHO, with
high or low RS (51% of energy CHO (27 g RS) and 53% CHO
(<2 g RS)), compared with low CHO, with high or low RS
(40% CHO (19 g RS) and 39% CHO (<1 g RS)). The authors
reported the Hi-Maize 260 supplement used for the study
comprised 41·5% RS(25). TMAO concentrations were sig-
nificantly higher on the high v. low RS intake, but the effect
was also dependent on dietary CHO intake(25). The authors
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Table 1. Daily consumption by food group pre- and post-intervention, showing within- and between-group changes†
(Mean values and standard deviations; medians and interquartile ranges (IQR); medians and 95% confidence intervals)
Food group
(serve size)
Paleolithic (n 22) AGHE (n 17)
Pre Post Change within group Pre Post Change within group
Difference between
groups (change)
Difference between groups
post-intervention
Mean SD Mean SD Median 95% CI Mean SD Mean SD Median 95% CI Median 95% CI Median 95% CI
Total grains 5·18 1·71 0·58 0·97 –4·60** –5·5, –3·7 4·42 1·95 4·50 1·93 0·08 –1·1, 1·3 –4·68** –6·1, –3·3 –3·92** –5·0, –2·9
Refined grains
(16 g starch
equivalent)
3·31 1·55 0·37 0·65 –2·94** –3·6, –2·3 2·54 1·61 2·42 1·53 –0·12 –1·2, 1·0 –2·82** –4·0, –1·6 –2·06** –2·9, –1·2
Whole grains (14 g
starch equivalent)
1·86 1·12 0·21 0·45 –1·65** –2·3, –1·1 1·87 1·34 2·07 1·36 0·20 –0·7, 1·1 –1·85** –2·9, –0·9 –1·86** –2·6, –1·1
Wholegrain
percentage‡
37·11 35·16 0·00 27·59 –29·17**§ –46·1, –5·7 41·34 37·80 55·25 46·66 5·68§ –12·8, 24·1 –34·33*|| –60·1, –7·4 –31·27**|| –60·8, –22·2
Total fruit‡ 1·52 0·62 3·06 1·85 1·36**§ 0·9, 2·0 1·65 1·00 1·18 1·43 –0·28§ –0·7, 0·2 1·59**|| 0·9, 2·3 1·53**|| 0·6, 2·4
Citrus, melons,
berries (fresh
equivalent 350 kJ,
dried 30 g)‡
0·16 0·41 0·22 0·71 0·06§ –0·1, 0·3 0·13 0·31 0·10 0·24 –0·02§ –0·1, 0·1 0·06|| –0·1, 0·3 0·11|| –0·02, 0·4
Other fruit (fresh
equivalent 350 kJ,
dried 30 g)‡
1·12 0·71 2·50 1·70 1·20**§ 0·8, 1·8 1·62 0·87 1·18 1·38 –0·18§ –0·6, 0·4 1·36**|| 0·7, 2·1 1·27**|| 0·45, 1·87
Fruit juice (125ml)‡ 0·00 0·00 0·0 0·0 0·0§ 0·0, 0·0 0·00 0·00 0·00 0·00 0·0§ 0·0, 0·0 0·0|| 0·0, 0·0 0·00|| 0·00, 0·00
Fruit juice
percentage‡
0·00 0·00 0·0 0·0 0·0§ 0·0, 0·0 0·00 0·00 0·00 0·00 0·0§ 0·0, 0·0 0·0|| 0·0, 0·0 0·00|| 0·00, 0·00
Total vegetables 3·51 1·10 5·76 2·77 2·25** 1·1, 3·5 4·45 2·05 4·00 2·06 –0·45 –1·7, 0·8 2·70** 1·0, 4·4 1·75* 0·1, 3·4
Dark green
vegetables (100 kJ
equivalent)
0·36 0·37 0·47 0·52 0·11 –0·1, 0·4 0·24 0·24 0·17 0·19 –0·07 –0·2, 0·1 0·18 –0·1, 0·5 0·29* 0·0, 0·5
Red and orange
vegetables
(150 kJ)‡
0·89 0·35 3·04 2·44 2·01**§ 1·2, 3·1 0·83 0·87 1·33 1·15 0·18§ –0·7, 0·6 2·15**|| 0·9, 3·1 1·60|| 0·7, 2·7
Tomatoes (150 kJ) 0·41 0·30 0·48 0·53 0·08 –0·2, 0·3 0·41 0·32 0·33 0·35 –0·08 –0·3, 0·2 0·16 –0·2, 0·5 0·16 –0·1, 0·5
Other red and
orange
vegetables‡
(150 kJ)
0·44 0·67 1·92 2·74 1·93**§ 1·0, 3·3 0·53 1·09 0·55 1·06 0·24§ –0·6, 0·7 1·90**|| 0·6, 3·2 1·31**|| 0·6, 2·7
Starchy vegetables
(250 kJ)
0·96 0·93 0·19 0·40 –0·77** –1·3, –0·3 1·43 1·86 0·79 1·16 –0·64* –1·2, –0·1 –0·12 –0·8, 0·6 –0·59* –1·2, 0·0
Potatoes (250 kJ) 0·73 0·80 0·18 0·39 –0·55* –0·1, –0·1 1·26 1·89 0·72 1·15 –0·54 –1·1, 0·0 –0·01 –0·7, 0·7 –0·54* –1·07, –0·01
Other starchy
vegetables
(250 kJ)‡
0·18 0·34 0·00 0·06 –0·17**§ –0·2, –0·1 0·00 0·18 0·01 0·10 0·0§ –0·2, 0·0 –0·04|| –0·2, 0·0 0·00|| –0·03, 0·00
Starchy vegetable
percentage
27·86 26·02 4·29 9·82 –23·58** –36·6, –10·6 29·90 26·65 18·70 25·70 –11·21 –22·7, 0·3 –12·37 –29·8, 5·0 –14·41** –28·1, –0·7
Legumes (350 kJ)‡ 0·00 0·15 0·00 0·03 –0·06*§ –0·1, 0·0 0·00 0·10 0·004 0·91 0·01§ –0·1, 0·5 –0·05|| –0·3, 0·0 –0·04*|| –0·4, 0·0
Other vegetables
(100 kJ)‡
0·96 0·72 1·64 1·49 0·68*§ 0·1, 1·3 1·27 0·67 1·27 1·51 0·21§ –0·3, 0·5 0·55|| –0·3, 1·5 0·43|| –0·2, 1·1
Total protein foods‡ 2·59 1·15 3·91 1·58 1·49**§ 0·9, 2·1 2·61 1·71 2·56 1·73 –0·22§ –0·90, 0·6 1·72**|| 0·8, 2·7 1·42**|| 0·6, 2·3
Red meat
(20 g Ptn)‡
0·50 0·74 1·36 1·36 0·65**§ 0·2, 1·1 0·32 1·22 0·00 0·59 –0·32§ –0·9, 0·0 1·02**|| 0·3, 1·7 0·92**|| 0·6, 1·5
Poultry (23 g Ptn)‡ 0·36 0·77 0·50 0·96 0·14§ –0·1, 0·5 0·69 0·98 0·52 0·82 0·07§ –0·4, 0·7 0·13|| –0·4, 0·7 –0·11|| –0·4, 0·3
Eggs (13 g Ptn)‡ 0·36 0·77 0·52 0·52 0·22*§ 0·1, 0·4 0·05 0·37 0·28 0·44 0·14§ 0·0, 0·3 0·07|| –0·2, 0·3 0·26*|| 0·04, 0·5
Processed meat
(20 g Ptn)‡
0·08 0·18 0·00 0·28 –0·01§ –0·1, 0·0 0·00 0·24 0·00 0·10 –0·03§ –0·1, 0·0 0·03|| 0·0, 0·1 0·00|| 0·00, 0·1
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Table 1. Continued
Food group
(serve size)
Paleolithic (n 22) AGHE (n 17)
Pre Post Change within group Pre Post Change within group
Difference between
groups (change)
Difference between groups
post-intervention
Mean SD Mean SD Median 95% CI Mean SD Mean SD Median 95% CI Median 95% CI Median 95% CI
Organ meat
(20 g Ptn)‡
0·00 0·00 0·0 0·0 0·0§ 0·0, 0·0 0·00 0·00 0·0 0·00 0·0§ 0·0, 0·0 0·00|| 0·0, 0·0 0·00|| 0·00, 0·00
Seafood high n-3
(23 g Ptn)‡
0·00 0·31 0·13 0·44 0·01§ 0·0, 0·2 0·00 0·09 0·02 0·30 0·05§ 0·0, 0·2 0·00|| –0·1, 0·1 0·00|| –0·2, 0·1
Seafood low n-3
(23 g Ptn)‡
0·00 0·25 0·05 0·49 0·0§ –0·1, 0·2 0·09 0·32 0·00 0·42 0·02§ –0·1, 0·2 0·00|| –0·2, 0·2 0·00|| –0·1, 0·2
Nuts and seeds
(30 g Ptn)‡
0·31 0·71 0·83 1·16 0·22§ –0·1, 0·6 0·54 0·47 0·45 0·69 –0·25§ –0·5, 0·1 0·45*|| 0·0, 0·9 0·07|| –0·3, 0·4
Legumes protein
(9 g Ptn)‡
0·00 0·08 0·00 0·03 –0·03*§ 0·1, 0·0 0·00 0·08 0·003 0·51 0·01§ 0·0, 0·3 –0·02*|| –0·2, 0·0 –0·00*|| –0·2, 0·0
Soya products
(9 g Ptn)‡
0·00 0·00 0·00 0·00 0·0§ 0·0, 0·0 0·0 0·00 0·00 0·00 0·0§ 0·0, 0·0 0·0|| 0·0, 0·0 0·00|| 0·0, 0·0
Total dairy products 1·57 0·71 0·09 0·19 –1·48** –1·8, –1·2 1·93 0·97 1·54 0·59 –0·39 –0·9, 0·1 –1·09** –1·6, –0·5 –1·45** –1·8, –1·1
Milk (300mg Ca) 0·84 0·48 0·08 0·17 –0·76** –1·0, –0·6 1·14 0·65 0·84 0·51 –0·30* –0·5, –0·1 –0·46** –0·8, –0·2 –0·76** –1·0, –0·5
Cheese (300 mg
Ca)‡
0·49 0·51 0·00 0·00 –0·47**§ –0·7, –0·3 0·41 0·62 0·30 0·45 –0·08§ –0·3, 0·2 –0·40**|| –0·7, –0·2 –0·30**|| –0·4, –0·2
Yogurt
(300mg Ca)‡
0·07 0·40 0·0 0·0 –0·19**§ –0·3, –0·03 0·19 0·39 0·18 0·40 0·01§ –0·1, 0·1 –0·16|| –0·3, –0·1 –0·18**|| –0·3, 0·0
Milk alternatives
(300mg Ca)‡
0·00 0·00 0·0 0·0 0·0§ 0·0, 0·0 0·00 0·00 0·00 0·00 0·0§ 0·0, 0·0 –0·00|| 0·0, 0·0 0·00|| 0·0, 0·0
Oil equivalents
(4·6 g, 1 tsp)‡
6·81 3·04 6·19 6·53 0·68§ –1·5, 2·8 7·89 5·23 7·10 4·03 –1·48§ –3·9, 1·3 1·93|| –1·1, 5·3 –0·44|| –2·5, 2·6
Solid fat
equivalents
(4·6 g, 1 tsp)‡
7·50 4·39 5·23 3·42 –2·00**§ –3·7, –0·7 8·82 4·11 5·38 2·85 –3·03*§ –4·6, –0·7 1·09|| –1·8, 3·1 –0·44|| –2·0, 1·0
Added sugars
(4·2 g, 1 tsp)
8·61 7·32 2·97 3·71 –5·64** –8·4, –2·9 6·34 4·52 3·83 2·38 –2·50* –4·4, –0·6 –3·13 –6·4, 0·1 –0·86 –3·0, 1·2
Added sugars (kJ) 578·39 492·18 199·64 248·98 –378·8** –561·7, –195·8 425·78 303·85 257·53 160·19 –168·25* –267·7, –38·8 –210·50 –427·9, 6·9 –57·89 –198·7, 82·9
Added sugars
(% of energy)
6·55 4·45 3·43 4·01 –3·12** –5·0, –1·2 4·93 2·96 4·00 2·48 –0·93 –2·4, 0·5 –2·19 –4·5, 0·1 –0·57 –2·8, 1·7
AGHE, Australian Guide to Healthy Eating; Ptn, protein; tsp, teaspoon.
*P<0·05, **P<0·01.
† Food group serve sizes as used by FoodWorks Professional(26). Normally distributed data were assessed using paired t tests and independent t tests.
‡ Non-normally distributed data. Results are shown as medians and IQR.
§ Non-normally distributed data were assessed using the Wilcoxon signed rank matched pair test; results are shown as median differences. The corresponding 95% CI were calculated using the Hodges–Lehmann estimator in SPSS.
|| Non-normally distributed data were assessed using the Mann–Whitney U test. Note that the 95% CI corresponding to the Mann–Whitney U test are given for the median differences and were determined using the Hodges–Lehmann
estimator in SPSS.
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concluded that both dietary CHO and RS intake influence the
production of TMA by colonic microbiota. However, the low-
CHO diets were also much higher in fat (40 and 41% of
energy, respectively). Previous research in rats indicated that
the benefits of RS supplementation were attenuated when the
animals were fed a high-fat diet (40–41% of energy)(40).
Therefore, a reduction in beneficial bacteria mediated by the
high-fat diet may have led to the increase in blood TMAO
concentrations. Without faecal biochemistry measurements,
such as SCFA concentrations, it is not possible to conclude
that the increase in TMAO was due to the RS supplementation
alone. Diets low in CHO and whole grains also have lower
content of other fermentable fibres that could influence the
gut microbiota, including oligosaccharides, β-glucans and
arabinoxylans(41). A full understanding of dietary modification
of TMAO concentrations can be gained with future measure-
ment of these variables in conjunction with RS. In our short-
term intervention, the reduction in RS intake and the relative
increases in meat and egg consumption did not impact serum
concentrations of TMAO, although we note the small effect
size of the TMAO result, and our small sample size may have
limited our ability to detect the differences in this area. Fur-
thermore, participants in both dietary intervention groups
decreased energy intake significantly(3), which is known to
impact the microbiota(42–44), and may have influenced the
ability of the microbiota to produce TMA. However, the link
between diet, the microbiota and TMAO is not yet well
understood, and larger, long-term research in this area is
required. Recent epidemiological and experimental evidence
has strengthened the link between red meat intake and col-
orectal cancer(45–47). Further research examining the long-
term health impacts of the Paleolithic diet is now warranted,
considering that RS intake is low on the dietary pattern.
Examination of TMAO concentrations with longer-term
adherence to a Paleolithic diet, which includes an examina-
tion of microbiota composition is recommended, aiding fur-
ther understanding of the role of dietary patterns, RS intake
and the microbiota in modulating TMAO concentrations and
CVD risk.
Our examination of fibre intake has highlighted limitations in
the current Australian fibre data. Older methods of measuring
total dietary fibre (AOAC 985.29 and 991.43) fail to capture/
quantify all CHO components that constitute dietary fibre, as
currently defined(48). For instance, they underestimate most
types of RS(48). Drawing conclusions linking dietary fibre frac-
tion intake with health outcomes is limited without having a
complete understanding of dietary fibre fraction composition;
thus, more research is now required to develop updated data-
bases in this area.
Despite the increased serves of fruits and vegetables
consumed in the Paleolithic group and the maintenance of
total dietary fibre intake, RS was negatively impacted by the
elimination of whole grains and cereals. Further research is
required to determine the effect of this reduction on the gut
microbiota and subsequent health outcomes; in particular,
the association with serum TMAO concentrations and CVD.
Furthermore, with increased understanding of the physio-
logical responses to fibre fractions, it is critical that theTa
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Australian and New Zealand fibre databases are updated to
include RS components to enable population health assess-
ment and establish epidemiological links with chronic
disease.
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